Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
3. Medtronic notches milestones in CoreValve TAVI research, adds lower-risk patients
Medtech titan Medtronic closes enrollment in its U.S. pivotal trial for the CoreValve transcatheter aortic valve implantation system and lands FDA approval to expand a separate CoreValve trial to lower-risk patients.
2. St. Jude announces layoffs, restructuring and an executive shuffle following bleak quarter
Following a tough 2nd quarter, St. Jude Medical plans to cut about 300 positions as it restructures its product divisions into separate implantable electronics and cardiovascular & ablation divisions, announcing an executive shakeup along the way.
1. Boston Scientific shakeup: Layoffs and restructuring ahead for cardiac business
Medical device giant Boston Scientific expects an untold number of layoffs in the next few months and the company will its cardiac device businesses into separate CRM and stent divisions.
